Clinical Trial Update: Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab [NA]

View source ↗

Summary

This completed clinical trial evaluated the use of a topical menadione lotion to alleviate skin discomfort and psychological distress in cancer patients receivi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• Cetuximab (cetuximab)
• Erlotinib hydrochloride (Erlotinib)
• Menadione Topical Lotion (menadione)
• Panitumumab (panitumumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Dermatologic Complications, Malignant Neoplasm | NA | Status: COMPLETED | Results posted: 2019-10-16